Handbook of Hypertension. Volume 6: Epidemiology of Hypertension

Artikelnummer 10124231

Contents Foreword, xi W.H. Birkenhäger and J.L. Reid Introduction, xiii C.J. Bulpitt I. Hypertension – a problem for the population 1. Hypertension in the community, 1 G.A. Rose II. Hypertension and cardiovascular disease 2. Hypertension as a cardiovascular risk factor, 15 W.B. Kannel and J. Stokes III III. Blood pressure, age and race 3. Blood pressure in children and adolescents, 35 D.E. Fixler 4. Blood pressure in adults and the elderly, 51 P.K. Whelton 5. Ethnic and geographic differences in blood pressure, 70 J.K. Cruickshank and D.G. Beevers IV. Blood pressure and the environment 6. Psychosocial factors and blood pressure, 89 M.G. Marmot 7. Physical activity and blood pressure, 104 R. Fagard, J.-R. M’Buyamba, J. Staessen, L. Vanhees and A. Amery V. Diet and hypertension 8. Blood pressure, calorie intake and obesity, 131 J. Staessen, R. Fagard and A. Amery 9. Blood pressure and alcohol consumption, 159 A.L. Klatsky 10. Blood pressure and sodium intake, 175 F.O. Simpson 11. Blood pressure and potassium consumption, 191 C.J. Bulpitt 12. Trace metals and human hypertension, 206 D.G. Beevers 13. Blood pressure, calcium and water hardness, 216 H. Kesteloot 14. Blood pressure and dietary fat, 230 P. Puska and J.M. Iacono VI. Secondary hypertension and mechanisms of blood pressure elevation 15. Secondary hypertension in the community, 249 G. Berglund 16. What has happened to malignant hypertension?, 255 P. Kincaid-Smith 17. Blood pressure and pressor systems, 266 M.J. Brown 18. Urinary kallikrein and its relation to blood pressure, 279 H.S. Margolius and S.H. Zinner VII. Blood pressure, the pill, pregnancy and diabetes 19. Blood pressure and the contraceptive pill, 289 R.J. Weir 20. Hypertension in pregnancy, 301 D.M. Campbell and P.J. Lewis 21. Blood pressure and diabetes mellitus, 318 J.H. Fuller VIII. Community control of hypertension – rationale 22. An appraisal of the large-scale trials of antihypertensive treatment, 331 S.G. Thompson 23. The prognosis of essential hypertension, 344 C.J. Bulpitt IX. Community control of hypertension in different countries 24. Community control of hypertension in the United States, 359 N.O. Borhani 25. Hypertension detection and management through the worksite in the United States, 373 M.H. Alderman and M.E. Stanback 26. Community control of hypertension in Finland, 387 J. Tuomilehto, A. Nissinen, P. Puska and J. Salonen 27. Control of hypertension in a Japanese community, 412 K. Ueda and T. Omae 28. Community control of hypertension in Belgium, 426 J.V. Joossens and J. Geobers 29. Community control in Israel: cardiovascular risk factor control, 440 R.J. Viskoper and D.S. Silverberg X. Problems in community control 30. Compliance, 453 B. Blackwell and M.C. Gutmann 31. The disadvantages of being labelled hypertensive, 473 L.A. Macdonald, D.L. Sackett, R.B. Haynes and D.W. Taylor 32. Cost-effectiveness, 487 L. Wilhelmsen 33. Advertizing and the treatment of hypertension, 497 G.E. Bauer, S.N. Hunyor and G. Stokes Index, 509

pp. 518